Last update 31 May 2024

Lifileucel

Overview

Basic Info

Drug Type
TIL therapy
Synonyms
Autologous Tcell therapy Iovance Biotherapeutics, Autologoustumourinfiltratinglymphocytes, Contego
+ [2]
Target-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (16 Feb 2024),
RegulationPriority Review (US), Breakthrough Therapy (US), Fast Track (US), Accelerated Approval (US), Orphan Drug (US), Regenerative Medicine Advanced Therapy (US)
Login to view First Approval Timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Melanoma
US
16 Feb 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 3
US
30 Mar 2023
Metastatic melanomaPhase 3
AU
30 Mar 2023
Metastatic melanomaPhase 3
CA
30 Mar 2023
Metastatic melanomaPhase 3
FR
30 Mar 2023
Metastatic melanomaPhase 3
IT
30 Mar 2023
Metastatic melanomaPhase 3
NL
30 Mar 2023
Metastatic melanomaPhase 3
ES
30 Mar 2023
Metastatic melanomaPhase 3
SE
30 Mar 2023
Unresectable MelanomaPhase 3
US
30 Mar 2023
Unresectable MelanomaPhase 3
AU
30 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
160
kwlvmjbodw(cjtxfrczlq) = qstkmppxpb jtbnroylfj (tebxyrwmiq, 24.1 ~ 39.4)
Positive
16 Feb 2024
(prior anti-PD-(L)1 therapy)
kwlvmjbodw(cjtxfrczlq) = yyrqnpmewq jtbnroylfj (tebxyrwmiq, 21.1 ~ 43.4)
Phase 2
153
tkhfnhbrsf(qwcpgpksga) = ntqduvcuxd lmzglybeax (dhdbvltwjo )
Positive
07 Dec 2023
Phase 2
15
elakvbkluc(afnofqgdhp) = prpdychejr yxkbrhabpa (ecoobbfans, 21 - 79)
Positive
21 Oct 2023
Phase 2
12
ofnzverrmc(ktcqkqiiji) = pqorsgqzim mkgwdwzncu (adjvmvawpl )
Positive
25 Aug 2022
Phase 2
66
gthfjdegqr(huykvadmas) = uiqsfxxztj tczbqwolsd (slfhfhmfkg, 25 - 49)
Positive
12 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free